{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:24:39Z","timestamp":1788607479377,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02448-w","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T21:14:44Z","timestamp":1668546884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insights into the Role of Compendial\/Biorelevant Media on the Supersaturation Behaviour of Drug Combination (Drug-Drug Interaction) and Precipitation Inhibition by Polymers"],"prefix":"10.1208","volume":"23","author":[{"given":"Prachi","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay T.","family":"Sangamwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"2448_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/acs.molpharmaceut.5b00655","volume":"13","author":"D Prasad","year":"2016","unstructured":"Prasad D, Chauhan H, Atef E. Role of molecular interactions for synergistic precipitation inhibition of poorly soluble drug in supersaturated drug\u2013polymer\u2013polymer ternary solution. Mol Pharmaceutics. 2016;13:756\u201365. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00655.","journal-title":"Mol Pharmaceutics"},{"key":"2448_CR2","doi-asserted-by":"publisher","first-page":"114978","DOI":"10.1016\/j.carbpol.2019.114978","volume":"222","author":"J Guan","year":"2019","unstructured":"Guan J, Liu Q, Jin L, Xu H, Wu H, Zhang X, et al. Synergistic effect of Soluplus and hyaluronic acid on the supersaturation maintenance of lovastatin: the facilitated in vitro-in vivo performance and improved physical stability. Carbohydr Polym. 2019;222:114978. https:\/\/doi.org\/10.1016\/j.carbpol.2019.114978.","journal-title":"Carbohydr Polym"},{"key":"2448_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejps.2018.04.024","volume":"119","author":"CBM Figueir\u00eado","year":"2018","unstructured":"Figueir\u00eado CBM, Nadvorny D, de Medeiros Vieira ACQ, de Medeiros Schver GCR, Sobrinho JLS, Neto PJR, et al. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. Eur J Pharm Sci. 2018;119:208\u201318. https:\/\/doi.org\/10.1016\/j.ejps.2018.04.024 (Elsevier).","journal-title":"Eur J Pharm Sci"},{"key":"2448_CR4","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1021\/acs.molpharmaceut.7b00203","volume":"14","author":"H\u00c7 Arca","year":"2017","unstructured":"Arca H\u00c7, Mosquera-Giraldo LI, Dahal D, Taylor LS, Edgar KJ. Multidrug, anti-HIV amorphous solid dispersions: nature and mechanisms of impacts of drugs on each other\u2019s solution concentrations. Mol Pharmaceutics. 2017;14:3617\u201327. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00203.","journal-title":"Mol Pharmaceutics"},{"key":"2448_CR5","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1002\/jps.24528","volume":"104","author":"NS Trasi","year":"2015","unstructured":"Trasi NS, Taylor LS. Thermodynamics of highly supersaturated aqueous solutions of poorly water-soluble drugs-impact of a second drug on the solution phase behavior and implications for combination products. J Pharm Sci. 2015;104:2583\u201393. https:\/\/doi.org\/10.1002\/jps.24528.","journal-title":"J Pharm Sci"},{"key":"2448_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2015.10.026","volume":"496","author":"NS Trasi","year":"2015","unstructured":"Trasi NS, Taylor LS. Dissolution performance of binary amorphous drug combinations\u2013impact of a second drug on the maximum achievable supersaturation. Int J Pharm. 2015;496:282\u201390. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.10.026.","journal-title":"Int J Pharm"},{"key":"2448_CR7","unstructured":"World Health Organization Model List of Essential Medicines \u2013 22nd List. 2021"},{"key":"2448_CR8","unstructured":"Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. 2017"},{"key":"2448_CR9","unstructured":"WHO. Schistosomiasis and soil-transmitted helminthiases: progress report, Weekly Epidemiological Record. World Health Organization; (2020) 96:585\u201395"},{"key":"2448_CR10","unstructured":"WHO. Weekly Epidemiological Record, 2021, vol. 96, 48. Weekly Epidemiological Record. World Health Organization; 96:585\u201396."},{"key":"2448_CR11","unstructured":"Al Amin ASM WR. Helminthiasis. tatPearls Publishing. 2022."},{"key":"2448_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.trstmh.2011.07.009","volume":"105","author":"H Namwanje","year":"2011","unstructured":"Namwanje H, Kabatereine NB, Olsen A. Efficacy of single and double doses of albendazole and mebendazole alone and in combination in the treatment of Trichuris trichiura in school-age children in Uganda Trans R Soc Trop Med Hyg. Royal Society of Tropical Medicine and Hygiene. 2011;105:586\u201390. https:\/\/doi.org\/10.1016\/j.trstmh.2011.07.009.","journal-title":"Royal Society of Tropical Medicine and Hygiene"},{"key":"2448_CR13","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1128\/AAC.01217-16","volume":"60","author":"N Cowan","year":"2016","unstructured":"Cowan N, Vargas M, Keiser J. In vitro and in vivo drug interaction study of two lead combinations, oxantel pamoate plus albendazole and albendazole plus mebendazole, for the treatment of soil-transmitted helminthiasis. Antimicrob Agents Chemother. 2016;60:6127\u201333. https:\/\/doi.org\/10.1128\/AAC.01217-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"2448_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-3305-5-292","volume":"5","author":"J Keiser","year":"2012","unstructured":"Keiser J, Tritten L, Adelfio R, Vargas M. Effect of combinations of marketed human anthelmintic drugs against Trichuris muris in vitro and in vivo. Parasit & Vectors. 2012;5:1\u20137. https:\/\/doi.org\/10.1186\/1756-3305-5-292.","journal-title":"Parasit & Vectors"},{"key":"2448_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1406-8","volume":"9","author":"B Speich","year":"2016","unstructured":"Speich B, Moser W, Ali SM, Ame SM, Albonico M, Hattendorf J, et al. Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole. Parasit & Vectors. 2016;9:1\u201310. https:\/\/doi.org\/10.1186\/s13071-016-1406-8.","journal-title":"Parasit & Vectors"},{"key":"2448_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4103\/1735-5362.194868","volume":"11","author":"S Ghanbarzadeh","year":"2016","unstructured":"Ghanbarzadeh S, Khalili A, Jouyban A, Emami S, Javadzadeh Y, Solhi M, et al. Dramatic improvement in dissolution rate of albendazole by a simple, one-step, industrially scalable technique. Res Pharm Sci. 2016;11:435. https:\/\/doi.org\/10.4103\/1735-5362.194868.","journal-title":"Res Pharm Sci"},{"key":"2448_CR17","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1021\/mp300224h","volume":"9","author":"S Carlert","year":"2012","unstructured":"Carlert S, \u00c5kesson P, Jerndal G, Lindfors L, Lennern\u00e4s H, Abrahamsson B. In vivo dog intestinal precipitation of mebendazole: a basic BCS class II drug. Mol Pharmaceutics. 2012;9:2903\u201311. https:\/\/doi.org\/10.1021\/mp300224h.","journal-title":"Mol Pharmaceutics"},{"key":"2448_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpharm.2010.10.002","volume":"403","author":"JJ Garc\u00eda-Rodriguez","year":"2011","unstructured":"Garc\u00eda-Rodriguez JJ, de la Torre-Iglesias PM, Vegas-S\u00e1nchez MC, Torrado-Dur\u00e1n S, Bol\u00e1s-Fern\u00e1ndez F, Torrado-Santiago S. Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity. Int J Pharm. 2011;403:23\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.10.002.","journal-title":"Int J Pharm"},{"key":"2448_CR19","doi-asserted-by":"publisher","first-page":"106014","DOI":"10.1016\/j.ejps.2021.106014","volume":"167","author":"P Joshi","year":"2021","unstructured":"Joshi P, Mallepogu P, Kaur H, Singh R, Sodhi I, Samal SK, et al. Explicating the molecular level drug-polymer interactions at the interface of supersaturated solution of the model drug: albendazole. Eur J Pharm Sci. 2021;167:106014. https:\/\/doi.org\/10.1016\/j.ejps.2021.106014.","journal-title":"Eur J Pharm Sci"},{"key":"2448_CR20","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","volume":"25","author":"E Jantratid","year":"2008","unstructured":"Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res. 2008;25:1663\u201376. https:\/\/doi.org\/10.1007\/s11095-008-9569-4.","journal-title":"Pharm Res"},{"key":"2448_CR21","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1021\/acs.molpharmaceut.8b00267","volume":"15","author":"I Sodhi","year":"2018","unstructured":"Sodhi I, Sangamwar AT. Microarray plate method for estimation of precipitation kinetics of celecoxib under biorelevant conditions and precipitate characterization. Mol Pharmaceutics. 2018;15:2423\u201336. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00267.","journal-title":"Mol Pharmaceutics"},{"key":"2448_CR22","doi-asserted-by":"publisher","first-page":"77569","DOI":"10.1080\/03639045.2018.1503295","volume":"6","author":"RB Chavan","year":"2016","unstructured":"Chavan RB, Thipparaboina R, Kumar D, Shastri NR. Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth. RSC Adv. 2016;6:77569\u201376. https:\/\/doi.org\/10.1080\/03639045.2018.1503295.","journal-title":"RSC Adv"},{"key":"2448_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejpb.2018.08.003","volume":"131","author":"T Pas","year":"2018","unstructured":"Pas T, Struyf A, Vergauwen B, Van den Mooter G. Ability of gelatin and BSA to stabilize the supersaturated state of poorly soluble drugs. E Eu J Pharm Biopharm. 2018;131:211\u201323. https:\/\/doi.org\/10.1016\/j.ejpb.2018.08.003.","journal-title":"E Eu J Pharm Biopharm"},{"key":"2448_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s11095-016-1871-y","volume":"33","author":"MJ Jackson","year":"2016","unstructured":"Jackson MJ, Kestur US, Hussain MA, Taylor LS. Characterization of supersaturated danazol solutions - impact of polymers on solution properties and phase transitions. Pharm Res. 2016;33:1276\u201388. https:\/\/doi.org\/10.1007\/s11095-016-1871-y.","journal-title":"Pharm Res"},{"key":"2448_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1208\/s12249-015-0458-y","volume":"17","author":"C Brough","year":"2016","unstructured":"Brough C, Miller DA, Keen JM, Kucera SA, Lubda D, Williams RO 3rd. Use of polyvinyl alcohol as a solubility-enhancing polymer for poorly water soluble drug delivery (part 1). AAPS PharmSciTech. 2016;17:167\u201379. https:\/\/doi.org\/10.1208\/s12249-015-0458-y.","journal-title":"AAPS PharmSciTech"},{"key":"2448_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/10837450.2016.1256409","volume":"23","author":"N-Q Shi","year":"2018","unstructured":"Shi N-Q, Lai H-W, Zhang Y, Feng B, Xiao X, Zhang H-M, et al. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology. Pharm Dev Technol. 2018;23:573\u201386. https:\/\/doi.org\/10.1080\/10837450.2016.1256409.","journal-title":"Pharm Dev Technol"},{"key":"2448_CR27","unstructured":"Ducheyne P, Healy KE, Hutmacher DW, Grainger DW, Kirkpatrick CJ. Comprehensive biomaterials [Internet]. Elsevier Science; 2015."},{"key":"2448_CR28","doi-asserted-by":"publisher","unstructured":"Gl\u00f6ckner G. Gradient polymer chromatography: liquid chromatography. In: Wilson ID, editor. Encyclopedia of Separation Science. Oxford: Academic Press; 2000. p. 2975\u201384. https:\/\/doi.org\/10.1016\/B0-12-226770-2\/01851-2","DOI":"10.1016\/B0-12-226770-2\/01851-2"},{"key":"2448_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4155\/tde-2018-0031","volume":"9","author":"P Joshi","year":"2018","unstructured":"Joshi P, Sangamwar AT. Stabilizing supersaturated drug-delivery system through mechanism of nucleation and crystal growth inhibition of drugs. Ther Deliv. 2018;9:873\u201385. https:\/\/doi.org\/10.4155\/tde-2018-0031.","journal-title":"Ther Deliv"},{"key":"2448_CR30","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1023\/a:1012167410376","volume":"14","author":"LS Taylor","year":"1997","unstructured":"Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 1997;14:1691\u20138. https:\/\/doi.org\/10.1023\/a:1012167410376.","journal-title":"Pharm Res"},{"key":"2448_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijpharm.2007.12.015","volume":"355","author":"W-G Dai","year":"2008","unstructured":"Dai W-G, Dong LC, Li S, Deng Z. Combination of Pluronic\/Vitamin E TPGS as a potential inhibitor of drug precipitation. Int J Pharm. 2008;355:31\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.12.015.","journal-title":"Int J Pharm"},{"key":"2448_CR32","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/jps.21899","volume":"99","author":"M Brits","year":"2010","unstructured":"Brits M, Liebenberg W, de Villiers MM. Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole. Pharm Sci. 2010;99:1138\u201351. https:\/\/doi.org\/10.1002\/jps.21899.","journal-title":"Pharm Sci"},{"key":"2448_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.apt.2015.05.006","volume":"26","author":"MK Raval","year":"2015","unstructured":"Raval MK, Vaghela PD, Vachhani AN, Sheth NR. Role of excipients in the crystallization of albendazole. Adv Powder Technol. 2015;26:1102\u201315. https:\/\/doi.org\/10.1016\/j.apt.2015.05.006.","journal-title":"Adv Powder Technol"},{"key":"2448_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jddst.2017.11.003","volume":"43","author":"KD Koradia","year":"2018","unstructured":"Koradia KD, Parikh RH, Koradia HD. Albendazole nanocrystals: optimization, spectroscopic, thermal and anthelmintic studies. J Drug Deliv Sci Technol. 2018;43:369\u201378. https:\/\/doi.org\/10.1016\/j.jddst.2017.11.003.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2448_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/bip.10041","volume":"67","author":"HY Aboul-Enein","year":"2002","unstructured":"Aboul-Enein HY, Bunaciu AA, Fleschin S. Analysis of mebendazole polymorphs by Fourier transform IR spectrometry using chemometric methods. Biopolymers. 2002;67:56\u201360. https:\/\/doi.org\/10.1002\/bip.10041.","journal-title":"Biopolymers"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02448-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T17:21:56Z","timestamp":1669656116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02448-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["2448"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02448-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"20 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"300"}}